| Literature DB >> 18328585 |
Laurence Valeyrie-Allanore1, Nicolas Poulalhon, Jean-Paul Fagot, Peggy Sekula, Batya Davidovici, Alexis Sidoroff, Maja Mockenhaupt.
Abstract
Amifostine is an organic thiophosphate prodrug used for cytoprotection against toxic effects of radiotherapy and chemotherapy. In a European prospective study of SJS/TEN, six patients were suspected to have SJS/TEN associated with amifostine. Our findings suggest that the risk of life-threatening cutaneous adverse reactions to amifostine could be significantly increased.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18328585 DOI: 10.1016/j.radonc.2008.01.021
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280